Physician profile

Johana Duque

Medical · Lauderdale Lakes, FL

NPI 1497057350

$13,912.59

in general payments reported to CMS, 2019-2025

41 companies · $3,378 in 2025

The $3,378 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).

See the full distribution for Medical

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,654.74
Education$215.19

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,558.29 2021-2025
Amgen INC. $1,490.65 2021-2025 Tavneos, Krystexxa, Uplizna
Mallinckrodt Hospital Products INC. $1,478.77 2021-2025 Acthar
Aurinia Pharma U.S., INC. $1,161.45 2021-2025 Lupkynis
Ucb, INC. $950.43 2021-2025 Bimzelx, Cimzia
Astrazeneca Pharmaceuticals LP $939.90 2021-2025 Saphnelo
Glaxosmithkline, LLC. $882.81 2021-2025 Benlysta
Janssen Biotech, INC. $757.33 2022-2025 Tremfya, Simponi Aria, Simponi
Ani Pharmaceuticals, INC. $590.41 2022-2025 Purified Cortrophin Gel
Radius Health, INC. $574.03 2021-2025 Tymlos
Horizon Therapeutics Plc $436.69 2021-2023 Krystexxa
E.R. Squibb & Sons, L.L.C. $398.36 2021-2025 Orencia
Boehringer Ingelheim Pharmaceuticals, INC. $325.59 2021-2025 Ofev, Jascayd
Lilly USA, LLC $283.09 2021-2025 Taltz
Alvogen INC $199.81 2021-2025 Teriparatide
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $196.86 2021-2025
Scilex Pharmaceuticals INC. $188.72 2024-2025
Kiniksa Pharmaceuticals International, Plc $171.02 2024 Arcalyst
Novartis Pharmaceuticals Corporation $162.59 2021-2025
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $120.02 2025 Xifaxan
Invivyd INC $110.64 2025 Pemgarda
Alnylam Pharmaceuticals INC. $99.82 2023 Amvuttra
Otsuka Pharmaceutical Development & Commercialization, INC. $97.48 2024
Organon LLC $86.42 2021-2025 Hadlima
Genzyme Corporation $82.40 2025
Pacira Therapeutics, INC. $73.34 2021
Kyowa Kirin, INC. $53.19 2023-2024 Crysvita
Fresenius Kabi USA, LLC $50.78 2023-2024 Idacio
Ibsa Pharma INC. $48.14 2021-2024 Tirosint, Licart
Sobi, INC $41.61 2025
Genentech USA, INC. $40.00 2025 Gazyva, Actemra
Cumberland Pharmaceuticals, INC. $38.77 2021-2022
Octapharma USA, INC. $31.93 2021
Tonix Medicines, INC. $30.91 2025 Tonmya
Actelion Pharmaceuticals US, INC. $29.80 2022
Fidia Pharma USA INC. $24.39 2024 Hymovis
Teva Pharmaceuticals USA, INC. $22.88 2024 Truxima
Celltrion USA INC. $22.33 2023 Yuflyma
Ultragenyx Pharmaceutical INC. $21.69 2021
Alexion Pharmaceuticals, INC. $19.94 2022
Genentech, INC. $19.31 2023 Actemra

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Johana Duque

$13,912.59

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $3,378 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).

https://glasscript.com/doctor/10524894/johana-duque

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.